Literature DB >> 15508314

Profiling analysis of oligosaccharides in antibody pharmaceuticals by capillary electrophoresis.

Satoru Kamoda1, Chie Nomura, Mitsuhiro Kinoshita, Saori Nishiura, Rika Ishikawa, Kazuaki Kakehi, Nana Kawasaki, Takao Hayakawa.   

Abstract

Carbohydrate chains in glycoprotein pharmaceuticals have important roles for the expression of their biological activities. Therefore, development of an assessment method for the carbohydrate chains is an important parameter for quality control of glycoprotein pharmaceuticals such as newly developed therapeutic antibodies. In this report, we applied capillary electrophoresis with laser-induced fluorescence detection to the analysis of carbohydrate chains after releasing with glycoamidase followed by derivatization with 3-aminobenzoic acid. We found that four major oligosaccharides present in antibody pharmaceuticals were successfully separated with good resolution. The present method showed good precision in both migration times and relative peak areas, and gave comparable accuracy with that using a derivatization method with 8-aminopyrene-1,3,6-trisulfonate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15508314

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  14 in total

1.  Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay.

Authors:  Bhavin S Parekh; Elaine Berger; Sharon Sibley; Suntara Cahya; Liqun Xiao; Melinda Ann LaCerte; Peter Vaillancourt; Scott Wooden; Dennis Gately
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

2.  Alterations in glycopeptides associated with herceptin treatment of human breast carcinoma mcf-7 and T-lymphoblastoid cells.

Authors:  Erika Lattová; Dorota Bartusik; Vic Spicer; Julia Jellusova; Hélène Perreault; Boguslaw Tomanek
Journal:  Mol Cell Proteomics       Date:  2011-05-24       Impact factor: 5.911

3.  Kinetics of N-Glycan Release from Human Immunoglobulin G (IgG) by PNGase F: All Glycans Are Not Created Equal.

Authors:  Yining Huang; Ron Orlando
Journal:  J Biomol Tech       Date:  2017-10-09

Review 4.  In vitro and in vivo modifications of recombinant and human IgG antibodies.

Authors:  Hongcheng Liu; Gomathinayagam Ponniah; Hui-Min Zhang; Christine Nowak; Alyssa Neill; Nidia Gonzalez-Lopez; Rekha Patel; Guilong Cheng; Adriana Z Kita; Bruce Andrien
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857

Review 5.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003-2004.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2009 Mar-Apr       Impact factor: 10.946

6.  Non-fucosylated therapeutic antibodies: the next generation of therapeutic antibodies.

Authors:  Katsuhiro Mori; Shigeru Iida; Naoko Yamane-Ohnuki; Yutaka Kanda; Reiko Kuni-Kamochi; Ryosuke Nakano; Harue Imai-Nishiya; Akira Okazaki; Toyohide Shinkawa; Akihito Natsume; Rinpei Niwa; Kenya Shitara; Mitsuo Satoh
Journal:  Cytotechnology       Date:  2007-10-31       Impact factor: 2.058

Review 7.  Glycan labeling strategies and their use in identification and quantification.

Authors:  L R Ruhaak; G Zauner; C Huhn; C Bruggink; A M Deelder; M Wuhrer
Journal:  Anal Bioanal Chem       Date:  2010-03-12       Impact factor: 4.142

8.  Molecular cloning, characterization, genomic organization and promoter analysis of the α1,6-fucosyltransferase gene (fut8) expressed in the rat hybridoma cell line YB2/0.

Authors:  Béatrice Teylaert; Edwige Meurice; Marie Bobowski; Anne Harduin-Lepers; Christine Gaucher; Alexandre Fontayne; Sylvie Jorieux; Philippe Delannoy
Journal:  BMC Biotechnol       Date:  2011-01-05       Impact factor: 2.563

9.  Modern Technologies for Creating Synthetic Antibodies for Clinical application.

Authors:  S M Deyev; E N Lebedenko
Journal:  Acta Naturae       Date:  2009-04       Impact factor: 1.845

10.  Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood.

Authors:  Shigeru Iida; Reiko Kuni-Kamochi; Katsuhiro Mori; Hirofumi Misaka; Miho Inoue; Akira Okazaki; Kenya Shitara; Mitsuo Satoh
Journal:  BMC Cancer       Date:  2009-02-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.